BEUDAMED
    FDA Adverse Event Injury Summary report: N

    EUFLEXXA PFS 20MG/2ML

    MDR report key: 11715902 · Received April 22, 2021

    Report

    Report Number
    MW5100950
    Event Type
    Injury
    Date Received
    April 22, 2021
    Date of Event
    March 21, 2021
    Report Date
    April 21, 2021
    Manufacturer
    FERRING PHARMACEUTICALS INC.
    Product Code
    MOZ
    UDI-DI
    55566410001
    Adverse Event
    Yes
    Report Source
    Voluntary report
    Reporter Occupation
    OTHER

    Narratives

    Description of Event or Problem · 1

    PATIENT REPORTS SEVERE PAIN IN KNEE SINCE GETTING THIRD INJECTION. FOLLOWED UP WITH MD AND THE DOCTOR DID NOT HAVE ANOTHER COURSE OF ACTION OR PLAN FOR PATIENT. PATIENT STATES SHE IS ALMOST TO THE POINT OF DISABILITY AND CANNOT WALK ANY LONGER WITHOUT USING A CANE.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    605297 EUFLEXXA PFS 20MG/2ML ACID, HYALURONIC, INTRAARTICULAR MOZ FERRING PHARMACEUTICALS INC. 55566410001

    Patients

    Seq Age Sex Outcome Treatment
    1 52 YR